11/09/2025
🔹 Regulatory Update for Pharma Industry
We are glad to share an important development:
The CDSCO has approved the FDC of Voglibose 0.2 mg + Metformin HCl (SR form) 500 mg, which now officially stands excluded from the list of unapproved FDCs (as per CDSCO notification, 10th Sept 2025).
💡 What this means for the Pharma sector:
✅ Legal clarity & regulatory approval for manufacturing and marketing
✅ Enhanced confidence among doctors to prescribe
✅ Stronger trust for distributors and partners
✅ Expanded opportunities in both domestic and export markets
At Shree Pramukh Labs Pvt. Ltd., we remain committed to providing safe, compliant, and effective formulations to our partners across India and global markets.
📞 For B2B/white-label partnerships, connect with us today.
@9081024222 @9726300222